Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
11.64
-0.07 (-0.60%)
Aug 15, 2025, 10:31 AM - Market open

Cogent Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-284.08-255.86-192.41-140.24-72.27-74.81
Upgrade
Depreciation & Amortization
4.54.353.595.881.990.72
Upgrade
Loss (Gain) From Sale of Assets
--0.01---7.49
Upgrade
Asset Writedown & Restructuring Costs
----0.4-44.81
Upgrade
Loss (Gain) From Sale of Investments
-9.54-7.62-5.17-1.64--
Upgrade
Stock-Based Compensation
40.0639.7430.6218.3711.696.02
Upgrade
Other Operating Activities
0.06--1.7-1.36-0.340.22
Upgrade
Change in Accounts Receivable
-----2
Upgrade
Change in Accounts Payable
7.651.364.812.362.75-2.45
Upgrade
Change in Unearned Revenue
------1.32
Upgrade
Change in Other Net Operating Assets
7.7310.246.63-1.61-2.58-3.55
Upgrade
Operating Cash Flow
-233.61-207.79-153.62-118.64-58.76-35.85
Upgrade
Capital Expenditures
-1.03-0.57-2.8-6.86-1.72-
Upgrade
Sale of Property, Plant & Equipment
-----0.32
Upgrade
Investment in Securities
201.1838.85-95.03-117.86--
Upgrade
Other Investing Activities
-----8.1
Upgrade
Investing Cash Flow
200.1538.28-97.82-124.72-1.728.42
Upgrade
Issuance of Common Stock
26.43226.15174.24174.3639.26140.56
Upgrade
Other Financing Activities
-0.8-11.7-10.7-10.8-1.29-12.76
Upgrade
Financing Cash Flow
72.85214.45163.54163.5637.98232.2
Upgrade
Net Cash Flow
39.3844.94-87.91-79.8-22.51204.77
Upgrade
Free Cash Flow
-234.65-208.36-156.42-125.5-60.48-35.85
Upgrade
Free Cash Flow Margin
------455.47%
Upgrade
Free Cash Flow Per Share
-2.08-2.00-1.96-2.13-1.56-3.23
Upgrade
Levered Free Cash Flow
-126.13-115.91-86.68-67.08-31.78-15.46
Upgrade
Unlevered Free Cash Flow
-125.93-115.91-86.68-67.08-31.78-15.46
Upgrade
Change in Working Capital
15.3811.611.440.750.18-5.32
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q